Skip to content
  • Sunday, 26 July 2026
  • 2:59 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Molecular Switch in Sperm Metabolism Offers New Pathways for Infertility Treatments and Male Contraception
Stem Cell & Regenerative Medicine

Molecular Switch in Sperm Metabolism Offers New Pathways for Infertility Treatments and Male Contraception

Dwi Wanna Jul 5, 2026 0

Researchers at Michigan State University have identified a critical molecular "switch" that governs the sudden surge of energy sperm require…

Read More
Stem Cell & Regenerative Medicine

Molecular Switch Discovery in Sperm Metabolism Paves the Way for Nonhormonal Male Contraceptives and Enhanced Infertility Treatments

Dwi Wanna Jun 2, 2026 0

Researchers at Michigan State University (MSU) have announced a significant breakthrough in reproductive biology, identifying a specific molecular "switch" that…

Read More
Stem Cell & Regenerative Medicine

Molecular Switch Discovery in Sperm Metabolism Offers New Pathways for Infertility Treatment and Nonhormonal Male Contraception

Dwi Wanna Apr 27, 2026 0

A breakthrough study led by researchers at Michigan State University has successfully identified a critical molecular "switch" that governs the…

Read More
Stem Cell & Regenerative Medicine

Molecular Switch Discovery in Sperm Metabolism Offers New Pathways for Infertility Treatment and Non-Hormonal Contraception

Dwi Wanna Apr 19, 2026 0

Researchers at Michigan State University (MSU) have identified a critical molecular "switch" that triggers a massive surge in sperm energy…

Read More
Stem Cell & Regenerative Medicine

Molecular Insights into Sperm Metabolism Reveal New Pathways for Male Contraception and Infertility Treatment

Dwi Wanna Apr 12, 2026 0

Researchers at Michigan State University (MSU) have identified a critical molecular "switch" that regulates the surge of energy sperm require…

Read More
Biotech & Genetic Research

Glioblastoma Immune Cells Hijack Fructose Metabolism to Suppress Anti-Tumor Responses, Unveiling a Novel Therapeutic Pathway.

Jia Lissa Mar 20, 2026 0

In a significant breakthrough that could reshape the therapeutic landscape for one of the most aggressive and intractable brain cancers,…

Read More
We can expect future smoky days. And — surprise — it makes no sense to fight every blazeScience News: A Century of Empowering Public Understanding of ScienceScience News: A Century of Empowering Public Understanding of ScienceFive Python Scripts Revolutionize Excel Data Management, Streamlining Tedious Tasks for Professionals
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ